ABLVVSGTBP• 6 Months (Normalized)
ABLV vs GTBP (Able View Global Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 5 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABLV Performance $2.4
+287.1%
Able View Global Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
+1270.79%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-983.69 pts
GTBP outperforming by 983.69 percentage points
ABLVGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABLV GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(126 dates)
| Date | ABLV Price | ABLV Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $2.40 | +287.10% | $6.10 | +1270.79% | -983.69% |
| Oct 01, 2026 | $2.10 | +238.81% | $- | - | |
| Sep 30, 2026 | $2.04 | +229.03% | $- | - | |
| Sep 29, 2026 | $1.78 | +187.10% | $6.88 | +1444.94% | -1257.84% |
| Sep 28, 2026 | $1.67 | +168.55% | $6.80 | +1428.09% | -1259.54% |
| Sep 25, 2026 | $1.30 | +109.68% | $6.89 | +1448.31% | -1338.63% |
| Sep 24, 2026 | $- | $6.83 | +1434.83% | - | |
| Sep 23, 2026 | $0.97 | +56.45% | $7.10 | +1495.51% | -1439.06% |
| Sep 22, 2026 | $1.01 | +62.90% | $- | - | |
| Sep 21, 2026 | $0.95 | +53.23% | $7.18 | +1513.48% | -1460.25% |
| Sep 18, 2026 | $0.90 | +45.16% | $7.16 | +1508.99% | -1463.83% |
| Sep 17, 2026 | $0.85 | +37.10% | $7.49 | +1583.15% | -1546.05% |
| Sep 16, 2026 | $0.92 | +48.39% | $7.81 | +1655.06% | -1606.67% |
| Sep 15, 2026 | $0.92 | +48.39% | $9.00 | +1922.47% | -1874.08% |
| Sep 14, 2026 | $0.98 | +58.06% | $11.63 | +2513.48% | -2455.42% |
Page 1 of 9